ArchiMed MED II Fund

https://www.archimed.group

	Start	2017-01-01 closing
	Group	ArchiMed (Group)
	Predecessor	ArchiMed MED I Fund
	Successor	ArchiMed MED III Fund
	Industry	ArchiMed MED II Fund
	Industry 2	HEALTH (HUMAN)
	Person	Guillaumot, Vincent (ArchiMed 2014 Partner + Co-Founder before JS Bio)

	Region	Lyon
	Country	France
	City	n. a.
		Address record changed: 2023-12-04

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	315,000,000 (fund size at closing (2017) 2017-01-01)


		Record changed: 2024-02-12

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for ArchiMed (Group)

[1] ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist"....
[2] ArchiMed SAS. (11/3/21). "Press Release: ArchiMed Buys Cube, an Innovative Provider of Membrane Protein Services for the Biopharma Research Market"....
[3] ArchiMed SAS. (10/5/21). "Press Release: ArchiMed Backs Xpress Biologics, a Leading Provider of Plasmid DNA for Advanced Therapy Medicinal Products"....
[4] Clean Cells SAS. (9/15/21). "Press Release: Clean Cells Invests over €13M in New Biopharmaceutical Production Site". Montaigu-Vendée, near Nantes....
[5] ArchiMed SAS. (8/5/21). "Press Release: ArchiMed Closes MED III at €650 Million Hard Cap in Less than Two Months"....
[6] ArchiMed SAS. (1/12/21). "Press Release: ArchiMed Buys Germany’s Zyto Group of Cancer Diagnostics Companies in Partnership with Owners and Management"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]